Week 3 Discussion Discussion Reflection Response – Ethical Dilemma After reviewing The Invisible Patients documentary, provide a reflection post addressing

Week 3 Discussion

Discussion Reflection Response – Ethical Dilemma

After reviewing The Invisible Patients documentary, provide a reflection post addressing each of the four following questions:

  1. How is the NP in the documentary a Disruptive Innovator?
  2. Discuss at least one relationship between your personal beliefs and values with this ethical dilemma/barrier.
  3. Describe at least one mechanism to overcome the barrier discussed.
  4. Examine the potential cost and benefits to this barrier.

MUST WATCH 90 MINUTE VIDEO TO GET ANSWERS 

Please note:

  • This is a reflection and therefore no references are needed nor expected. NO APA NEEDED 
  • Your response should be minimum 300 words in length.
  • VIDEO:
  • Supplemental ReadingWatch the documentary “The Invisible Patients” (90 minutes) Produced by Patrick O’Connor 
  • The Joint Commission. (2015). 2015 national patient safety goals. Retrieved from 
  • Watch Professional Behavior, Attitude, and Attire: Professionalism
  • LINK TO VIDEO 

Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

General Instructions Identify one vulnerable population within a selected community. Explore current literature and related data to understand better the

General Instructions Identify one vulnerable population within a selected community. Explore current literature and related data to understand better the variables that place this population at risk for health concerns and health disparities. Analyze national health directives, such as Healthy People 2030 or another national initiative, to determine the correlation

The field of pharmacology has witnessed significant advancements in the treatment of endocrine disorders. Among the newer medications, Mounjaro and

The field of pharmacology has witnessed significant advancements in the treatment of endocrine disorders. Among the newer medications, Mounjaro and Ozempic have gained attention due to their efficacy in managing conditions such as type 2 diabetes and obesity. Discuss about similarities, differences, and clinical implications of these two new drugs. 

Select one of the safety quality issues (ensuring patients understand their condition, treatment options and care plans) and incorporate evidence-based

Select one of the safety quality issues (ensuring patients understand their condition, treatment options and care plans) and incorporate evidence-based strategies to support communication and ensure safe and effective care. For this assessment, be sure to focus on an organizational setting. This will be hospital ED setting. Then use the literature

Bring in examples of advertising or of the supplements that promise dieting, fad diets, nutritional supplements to make hair regrow or to relieve stress,

Bring in examples of advertising or of the supplements that promise dieting, fad diets, nutritional supplements to make hair regrow or to relieve stress, or any of the numerous products that make promises to consumers. Which of the promises do you believe? DISCUSSION POST                                300 words (minimum) APA or

The field of pharmacology has witnessed significant advancements in the treatment of endocrine disorders. Among the newer medications, Mounjaro and

The field of pharmacology has witnessed significant advancements in the treatment of endocrine disorders. Among the newer medications, Mounjaro and Ozempic have gained attention due to their efficacy in managing conditions such as type 2 diabetes and obesity. Discuss about similarities, differences, and clinical implications of these two new drugs. 

Case Study 1: Hypertension Management in a 50-Year-Old Patient Objective: Understand the pharmacologic treatment of hypertension, evaluate drug

Case Study 1: Hypertension Management in a 50-Year-Old Patient Objective: Understand the pharmacologic treatment of hypertension, evaluate drug interactions, and individualize care plans. Patient Profile: Age: 50 Gender: Male Height/Weight: 5’9”, 230 lbs Medical History: Hypertension (diagnosed 3 years ago), Type 2 Diabetes (well-controlled with metformin), elevated cholesterol Current Medications:

Patient-Centered Care and Health Information Technology [WLOs: 1, 2] [CLOs: 1, 3, 4, 6] Prior to beginning work on this discussion forum,Read Chapter 8

Patient-Centered Care and Health Information Technology [WLOs: 1, 2] [CLOs: 1, 3, 4, 6] Prior to beginning work on this discussion forum, Read Chapter 8 from your course textbook, McLaughlin and Kaluzny’s Continuous Quality Improvement in Health Care (5th ed.). Review the following articles: Artificial Intelligence and the Ongoing Need for Empathy,